Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06140927 · ClinicalTrials.gov registry record · Phase 3
Effect of Ketamine on Intraoperative Motor Evoked Potentials
A Phase 3 study of Spinal Stenosis and Spine Fusion, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06140927 is a Phase 3 study of Spinal Stenosis and Spine Fusion that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 549-participant average among 15 other Spinal Stenosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06140927, a Phase 3 study of Spinal Stenosis and Spine Fusion, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered increasing doses of ketamine with motor-evoked potentials being measured at each dose, to assess any impacts.
Conditions Studied
Interventions
- DRUG Ketamine
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06140927
The ClinicalTrials.gov registry entry for NCT06140927 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 549-participant average among 15 other Spinal Stenosis trials with a reported enrollment target (96% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Spinal Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.
NCT06140927 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06140927 about?
NCT06140927 is a clinical study titled "Effect of Ketamine on Intraoperative Motor Evoked Potentials". The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered inc...
What is the current status of trial NCT06140927?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2023-12-01. Estimated completion is 2026-12-01.
What conditions does trial NCT06140927 study?
This clinical trial studies the following conditions: Spinal Stenosis, Spine Fusion, Spine Tumor.
What interventions are being tested in trial NCT06140927?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT06140927?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06140927 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Greenwich Lumbar Stenosis SLIP Study
COMPLETED · Phase 3
-
OssDsign® Spine Registry Study ("Propel")
RECRUITING
-
Pulse-Width Modulation
RECRUITING · NA
-
Thoracic-Lumbar Arthrodesis- Implanet Jazz
RECRUITING
-
PREventing Pain After Surgery
RECRUITING · NA
-
Personalized Spine Study Group (PSSG) Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.